Objective To systematically evaluate the measurement characteristics and methodological quality of Chinese-version inflammatory bowel disease (IBD) disability measurement tools.

Methods A systematic search was conducted in PubMed, Web of Science, CNKI, WanFang Database and VIP Database for studies related to the evaluation of measurement characteristics of disability measurement tools for IBD patients, with a search period from inception to September 12, 2023. Based on the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) requirements, two researchers independently screened the literature and extracted the relevant data. The COSMIN risk of bias checklist and quality criteria rating scale were used to assess the measurement characteristics and formulate final recommendations.

Results Five studies were included in this study, involving four Chinese-version IBD disability measurement tools. None of the included studies fully reported the 10 measurement characteristics recommended by the COSMIN methodological quality criteria. The final included measurement tools were all rated as Grade B or C recommendations.

Conclusion It is recommended that the Chinese-version IBD Disability Index and the Chinese-translated IBD Patient Burden Scale can be temporarily used in clinical practice to assess ability in patients with inflammatory bowel disease, but their measurement characteristics still require further validation.